Fedratinib (Standard)
Fedratinib (Standard) is the analytical standard of Fedratinib. This product is intended for research and analytical applications. Fedratinib (TG-101348) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor with IC50s of 3 nM for both JAK2 and JAK2V617F kinase. Fedratinib shows 35- and 334-fold selectivity over JAK1 and JAK3, respectively. Fedratinib induces cancer cell apoptosis and has the potential for myeloproliferative disorders research[1][2].
Product Specifications
CAS Number
936091-26-8
Product Name Alternative
TG-101348 (Standard) ; SAR 302503 (Standard)
UNSPSC
12352005
Target
Apoptosis; JAK; Reference Standards
Related Pathways
Apoptosis; Epigenetics; JAK/STAT Signaling; Others; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Cancer
Smiles
O=S(C1=CC=CC(NC2=NC(NC3=CC=C(C=C3)OCCN4CCCC4)=NC=C2C)=C1)(NC(C)(C)C)=O
Molecular Formula
C27H36N6O3S
Molecular Weight
524.68
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Statherin (STATH) (NM_003154) Human Recombinant Protein
4-Nitrophenyl 2-O-(alpha-D-Mannopyranosyl)-alpha-D-mannopyranoside
Human Kappa Light Chain (HP6053), CF640R conjugate, 0.1mg/mL
TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (VEGI/2052R), CF488A conjugate, 0.1mg/mL
